Lifevantage (LFVN) EBITDA (2010 - 2026)

Lifevantage (LFVN) has reported EBITDA for 17 consecutive years, with $1.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBITDA fell 22.39% year-over-year to $1.7 million; the trailing twelve-month figure through Jun 2026 stood at $6.1 million (down 50.0% YoY), and the FY2026 full-year result was $6.1 million, down 50.0% from the prior year.
• EBITDA slipped to $1.7 million in Q2 2026 per LFVN's latest filing, from $1.7 million in the prior quarter.
• Across five years, EBITDA topped out at $4.1 million in Q1 2025 and bottomed at -$1.3 million in Q4 2023.
• Historically, EBITDA has averaged $1.7 million across 5 years, with a median of $1.8 million in 2022.
• The sharpest annual moves came in 2022 and 2024: EBITDA plunged 244.13% in 2022, then soared 371.85% in 2024.
• Over 5 years, EBITDA stood at -$1.2 million in 2022, then fell by 2.35% to -$1.3 million in 2023, then jumped by 371.85% to $3.4 million in 2024, then sank by 85.79% to $487000.0 in 2025, then jumped by 242.3% to $1.7 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $1.7 million, $1.7 million, and $487000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.